Do I qualify for Wegovy?
Check your BMI and health conditions against the FDA label criteria for Wegovy, Zepbound, Saxenda, Ozempic and Mounjaro. Free, instant, no signup.
Read this first. This checks your numbers against the criteria printed on the FDA label for each medication. It is not a prescription, not a diagnosis, and not a coverage decision. Only a licensed clinician can prescribe, and only your insurer can tell you what it will pay for. The criteria below are the adult ones.
Tick anything a clinician has actually diagnosed. On the weight-loss labels, one of these drops the BMI threshold from 30 down to 27.
What each label says for your numbers
| Medication | Label criteria | You |
|---|
How the math works
1. Work out BMI. In metric it is weight in kilograms divided by height in metres squared. In imperial it is weight in pounds, times 703, divided by height in inches squared. A 5 foot 6 adult at 205 lb has a BMI of about 33.1.
2. Compare it to the label. Wegovy, Zepbound and Saxenda are approved for adults with a BMI of 30 or above, or a BMI of 27 or above plus at least one weight-related condition. That second branch is the one most people miss. If your BMI is 27 to 29.9 and you have high blood pressure, sleep apnea, high cholesterol, heart disease or type 2 diabetes, you are inside the label.
3. Diabetes drugs are a different question. Ozempic and Mounjaro are approved to improve blood sugar in adults with type 2 diabetes. They are not approved for weight loss on their own, even at a high BMI. They contain the same molecules as Wegovy and Zepbound, which is why prescribers point people at the weight-loss brand instead.
Meeting the label is step one of three
Step one: the label
That is what this page checks. It is arithmetic against published criteria.
Step two: the prescriber
A clinician has to agree the medication is appropriate for you, and has to rule out the contraindications. A personal or family history of medullary thyroid carcinoma or MEN 2 rules these drugs out entirely. Pregnancy, a history of pancreatitis, active gallbladder disease, severe gastrointestinal disease and some eating disorder histories all change the conversation. Nothing on this page substitutes for that assessment.
Step three: coverage
This is where most people actually get stuck. Insurers routinely set rules that sit on top of the FDA label: a higher BMI floor, documented supervised weight-loss attempts, a prior authorisation, or a plan that excludes weight-loss medication altogether no matter what your BMI is. Meeting the label and getting it paid for are separate fights.
Where BMI falls down
BMI does not know the difference between muscle and fat, and it was never designed to assess an individual. A very muscular person can land in the obesity range with low body fat. BMI also reads differently across populations: several bodies recommend lower thresholds for people of South Asian, Chinese, and other Asian ancestry, where cardiometabolic risk shows up at a lower BMI. Treat the number as a screening input for a conversation, not a verdict on your health.
Want this tracked for you?
GLPme logs every shot, remembers your titration schedule, warns you before you run out of medication, and shows your weight trend against your goal. Core tracking is free.
More free tools
- Semaglutide unit calculator (compounded mg to syringe units)
- Tirzepatide unit calculator (compounded mg to syringe units)
- GLP-1 titration schedule (dose steps and dates)
- Switching GLP-1 medications (what dose do I restart on)
- Missed a dose (what the label says to do)
- Vial supply calculator (when do I run out, when do I reorder)
- How much protein on Wegovy? (daily protein target)
- GLP-1 cost calculator (what it costs per pound lost)
- GLP-1 weight loss projection (when will I hit my goal)
- All free GLP-1 tools